174 related articles for article (PubMed ID: 14731213)
21. Evaluation of Plasma Thrombomodulin in Patients with Coronary Slow Flow.
Wang Y; Jia PY; Chen BJ; Chen Y; Yu H; Yu Y; Yang HM; Jia DL; Ma CY
Cardiology; 2017; 138(3):141-146. PubMed ID: 28651248
[TBL] [Abstract][Full Text] [Related]
22. The effects of endothelial dysfunction and inflammation on slow coronary flow.
Arı H; Arı S; Erdoğan E; Tiryakioğlu O; Huysal K; Koca V; Bozat T
Turk Kardiyol Dern Ars; 2010 Jul; 38(5):327-33. PubMed ID: 21200102
[TBL] [Abstract][Full Text] [Related]
23. Target-organ damage in adolescent hypertension. Analysis of potential influencing factors, especially nitric oxide and endothelin-1.
Katona E; Settakis G; Varga Z; Paragh G; Bereczki D; Fülesdi B; Páll D
J Neurol Sci; 2006 Sep; 247(2):138-43. PubMed ID: 16737713
[TBL] [Abstract][Full Text] [Related]
24. Elevated level of plasma homocysteine in patients with slow coronary flow.
Riza Erbay A; Turhan H; Yasar AS; Ayaz S; Sahin O; Senen K; Sasmaz H; Yetkin E
Int J Cardiol; 2005 Jul; 102(3):419-23. PubMed ID: 16004886
[TBL] [Abstract][Full Text] [Related]
25. Carotid intima-media thickness in coronary slow flow: relationship with plasma homocysteine levels.
Tanriverdi H; Evrengul H; Tanriverdi S; Kuru O; Seleci D; Enli Y; Kaftan A; Kilic M
Coron Artery Dis; 2006 May; 17(4):331-7. PubMed ID: 16707955
[TBL] [Abstract][Full Text] [Related]
26. The association between coronary flow rate and impaired heart rate recovery in patients with metabolic syndrome: A preliminary report.
Alihanoglu YI; Kilic ID; Evrengul H; Yildiz BS; Alur I; Uludag B; Kuru O; Taskoylu O; Kaftan HA
Cardiol J; 2014; 21(3):257-64. PubMed ID: 23990190
[TBL] [Abstract][Full Text] [Related]
27. Effects of tumor necrosis factor, endothelin and nitric oxide on hyperdynamic circulation of rats with acute and chronic portal hypertension.
Wang JJ; Gao GW; Gao RZ; Liu CA; Ding X; Yao ZX
World J Gastroenterol; 2004 Mar; 10(5):689-93. PubMed ID: 14991939
[TBL] [Abstract][Full Text] [Related]
28. Plasma nitric oxide level and its role in slow coronary flow phenomenon.
Sezgin N; Barutcu I; Sezgin AT; Gullu H; Turkmen M; Esen AM; Karakaya O
Int Heart J; 2005 May; 46(3):373-82. PubMed ID: 16043934
[TBL] [Abstract][Full Text] [Related]
29. Hemodynamic changes during hemodialysis: role of nitric oxide and endothelin.
Raj DS; Vincent B; Simpson K; Sato E; Jones KL; Welbourne TC; Levi M; Shah V; Blandon P; Zager P; Robbins RA
Kidney Int; 2002 Feb; 61(2):697-704. PubMed ID: 11849413
[TBL] [Abstract][Full Text] [Related]
30. Effect of coronary angiography on plasma endothelin-1 and nitric oxide concentrations.
Orem A; Orem C; Alioğlu Y; Vanizor B; Erdöl C
Angiology; 2001 Apr; 52(4):231-5. PubMed ID: 11330504
[TBL] [Abstract][Full Text] [Related]
31. Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow.
Selcuk MT; Selcuk H; Temizhan A; Maden O; Ulupinar H; Baysal E; Ozeke O; Sasmaz A
Coron Artery Dis; 2007 Nov; 18(7):545-51. PubMed ID: 17925608
[TBL] [Abstract][Full Text] [Related]
32. Basal and flow-mediated nitric oxide production by atheromatous coronary arteries.
Tousoulis D; Tentolouris C; Crake T; Toutouzas P; Davies G
J Am Coll Cardiol; 1997 May; 29(6):1256-62. PubMed ID: 9137221
[TBL] [Abstract][Full Text] [Related]
33. The effects of perindopril on QT duration and dispersion in patients with coronary slow flow.
Guntekin U; Gumrukcuoglu HA; Gunes Y; Gunes A; Simsek H; Sahin M; Sezen Y; Akdağ S; Tuncer M
Heart Vessels; 2011 Jul; 26(4):357-62. PubMed ID: 21140270
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of coronary microvascular function and nitric oxide synthase intron 4a/b polymorphism in patients with coronary slow flow.
Ekmekci A; Güngör B; Özcan KS; Abaci N; Ilhan E; Ekmekci SS; Kemaloğlu T; Osmonov D; Ustek D; Eren M
Coron Artery Dis; 2013 Sep; 24(6):461-7. PubMed ID: 23811833
[TBL] [Abstract][Full Text] [Related]
35. The angiographic and clinical benefits of mibefradil in the coronary slow flow phenomenon.
Beltrame JF; Turner SP; Leslie SL; Solomon P; Freedman SB; Horowitz JD
J Am Coll Cardiol; 2004 Jul; 44(1):57-62. PubMed ID: 15234407
[TBL] [Abstract][Full Text] [Related]
36. Intimal hyperplasia and coronary flow reserve after heart transplantation: association with big endothelin-1.
Wexberg P; Pacher R; Rödler S; Kiss K; Beran G; Grimm M; Maurer G; Glogar D
J Heart Lung Transplant; 2002 Dec; 21(12):1257-63. PubMed ID: 12490270
[TBL] [Abstract][Full Text] [Related]
37. Effects of slow coronary artery flow on QT interval duration and dispersion.
Atak R; Turhan H; Sezgin AT; Yetkin O; Senen K; Ileri M; Sahin O; Karabal O; Yetkin E; Kutuk E; Demirkan D
Ann Noninvasive Electrocardiol; 2003 Apr; 8(2):107-11. PubMed ID: 12848790
[TBL] [Abstract][Full Text] [Related]
38. Increased mean platelet volume in patients with slow coronary flow.
Sen N; Basar N; Maden O; Ozcan F; Ozlu MF; Gungor O; Cagli K; Erbay AR; Balbay Y
Platelets; 2009 Feb; 20(1):23-8. PubMed ID: 19172518
[TBL] [Abstract][Full Text] [Related]
39. Effects of exercise training of 8 weeks and detraining on plasma levels of endothelium-derived factors, endothelin-1 and nitric oxide, in healthy young humans.
Maeda S; Miyauchi T; Kakiyama T; Sugawara J; Iemitsu M; Irukayama-Tomobe Y; Murakami H; Kumagai Y; Kuno S; Matsuda M
Life Sci; 2001 Jul; 69(9):1005-16. PubMed ID: 11508642
[TBL] [Abstract][Full Text] [Related]
40. Assessment of risk factors and left ventricular function in patients with slow coronary flow.
Li Y; Wang Y; Jia D; Lv Y; Zhang Y; Guan Z; Ma C
Heart Vessels; 2016 Mar; 31(3):288-97. PubMed ID: 25475386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
